December 4, 2018
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 104 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Read moreNovember 28, 2018
Fed Chairman Jerome Powell has been largely silent recently, and even cancelled his previous Federal Open Market Committee (FOMC) news conference. So, Wall Street was all ears when Powell gave a speech at The Economic Club of New York on Wednesday.
Read moreNovember 26, 2018
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 105 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Read moreNovember 19, 2018
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 114 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Read moreNovember 14, 2018
With NVIDIA Inc.’s third-quarter earnings report just around the corner, should we sell NVDA? Or, should we continue holding it through earnings? Let's find out.
Read moreNovember 13, 2018
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 129 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Read moreNovember 7, 2018
At first, it didn't look pretty. Shares of Medifast Inc. (MED) plunged after the nutrition company reported its third-quarter results. Apparently, there were conflicting reports on whether Medifast met or missed analysts' expectations. However, appearances can be deceiving, and there's much more to the Medifast story than meets the eye. So, let's get to the bottom of the MED selloff and what our best action is going forward.
Read moreNovember 5, 2018
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 129 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Read moreNovember 1, 2018
In this interest rate environment, dividends are still looking great. But you still have to do your homework and screen dividend stocks for fundamental health. And now is the perfect time to do so because we're coming up on a bunch of ex-dividend dates over the next few weeks…full details here. Read more
October 30, 2018
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 92 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Read moreOctober 24, 2018
You've probably heard me say, "Our best offense is a strong defense of fundamentally superior stocks." In light of all the recent market gyrations, this statement rings even more true as the current third-quarter earnings season heats up. Today, I'll review three prime defensive plays that have just reported earnings, and my current advice for each stock. Read more